Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities

ClinicalTrials.gov ID: NCT05051579

Public ClinicalTrials.gov record NCT05051579. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 9:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of the study was to assess the effect of LY3502970 in participants who have obesity or are overweight.

Study identification

NCT ID
NCT05051579
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
272 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 29, 2021 (Actual)
Primary completion
Aug 25, 2022 (Actual)
Completion
Nov 22, 2022 (Actual)
Last update posted
Sep 13, 2023

2021 – 2022

United States locations

U.S. sites
18
U.S. states
10
U.S. cities
18
Facility City State ZIP Site status
Anaheim Clinical Trials, LLC Anaheim California 92801 —
John Muir Physician Network Research Center Concord California 94520 —
NorCal Medical Research, Inc Greenbrae California 94904 —
Valley Clinical Trials, Inc. Northridge California 91325 —
Norcal Endocrinology & Internal Medicine San Ramon California 94583 —
Elite Clinical Trials Blackfoot Idaho 83221 —
Rocky Mountain Clinical Research Idaho Falls Idaho 83404 —
StudyMetrix Research City of Saint Peters Missouri 63303 —
Premier Research Trenton New Jersey 08611 —
Lillestol Research Fargo North Dakota 58104 —
Intend Research, LLC Norman Oklahoma 73069 —
Capital Area Research, LLC Camp Hill Pennsylvania 17011 —
Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair Pittsburgh Pennsylvania 15243 —
Dallas Diabetes Research Center Dallas Texas 75230 —
Diabetes and Thyroid Center of Fort Worth Fort Worth Texas 76132 —
Texas Diabetes & Endocrinology, P.A. Round Rock Texas 78681 —
National Clinical Research, Inc Richmond Virginia 23294 —
St. Vincent Hospital d/b/a Prevea Health Green Bay Wisconsin 54303 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05051579, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 13, 2023 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05051579 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →